Volume 95 Issue 41 | p. 17 | Concentrates
Issue Date: October 16, 2017

CordenPharma will buy a Pfizer pharmaceutical plant

Department: Business
Keywords: Pharmaceutical chemicals, APIs, peptides

The pharmaceutical chemical company CordenPharma has agreed to acquire a high-containment active pharmaceutical ingredient (API) facility from Pfizer in Boulder, Colo. The plant, which Pfizer acquired as part of its 2015 purchase of Hospira, has production capabilities ranging from small scale to 3,000 L and more than 100 employees. CordenPharma, which is part of International Chemical Investors Group, has acquired several API plants in recent years, including a Roche peptides facility that’s also in Boulder.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment